Search Results

There are 9015 results for: content related to: Retrospective evaluation of doxorubicin–piroxicam combination for the treatment of transitional cell carcinoma in dogs

  1. Melatonin protects against piroxicam-induced gastric ulceration

    Journal of Pineal Research

    Volume 36, Issue 3, April 2004, Pages: 195–203, Debashis Bandyopadhyay, Goutam Ghosh, Arun Bandyopadhyay and Russel J. Reiter

    Version of Record online : 8 MAR 2004, DOI: 10.1111/j.1600-079X.2004.00118.x

  2. Single dose oral piroxicam for acute postoperative pain

    Intervention Review

    The Cochrane Library

    R Andrew Moore, Jayne Edwards, Yoon Loke, Sheena Derry and Henry J McQuay

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD002762

  3. Influence of environment on piroxicam polymorphism: Vibrational spectroscopic study

    Biopolymers

    Volume 62, Issue 1, 2001, Pages: 68–78, Paola Taddei, Armida Torreggiani and Rosa Simoni

    Version of Record online : 15 DEC 2000, DOI: 10.1002/1097-0282(2001)62:1<68::AID-BIP80>3.0.CO;2-X

  4. Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam

    Veterinary and Comparative Oncology

    L. R. Eichstadt, G. E. Moore and M. O. Childress

    Version of Record online : 6 OCT 2016, DOI: 10.1111/vco.12276

  5. You have free access to this content
    Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Piroxicam

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 367–377, Igor E. Shohin, Julia I. Kulinich, Galina V. Ramenskaya, Bertil Abrahamsson, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah, D. W. Groot, Dirk M. Barends and Jennifer B. Dressman

    Version of Record online : 2 DEC 2013, DOI: 10.1002/jps.23799

  6. Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the cat

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 28, Issue 5, October 2005, Pages: 447–452, H. L. HEEB, R. CHUN, D. E. KOCH, L. MOORE, M. RADLINSKY, M. CORSE, M. A. PELLERIN, L. GARRETT and R. P. HUNTER

    Version of Record online : 5 OCT 2005, DOI: 10.1111/j.1365-2885.2005.00682.x

  7. You have free access to this content
    Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1

    International Journal of Cancer

    Volume 107, Issue 5, 10 December 2003, Pages: 830–836, Haiming Ding, Chunhua Han, Ruth Gibson-D′Ambrosio, Vernon E. Steele and Steven M. D′Ambrosio

    Version of Record online : 12 SEP 2003, DOI: 10.1002/ijc.11499

  8. Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria

    Inflammatory Bowel Diseases

    Volume 11, Issue 12, December 2005, Pages: 1060–1069, Laura P Hale, Marcia R Gottfried and Alexander Swidsinski

    Version of Record online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000187582.90423.bc

  9. You have free access to this content
    Physiologically Motivated Time-Delay Model to Account for Mechanisms Underlying Enterohepatic Circulation of Piroxicam in Human Beings

    Basic & Clinical Pharmacology & Toxicology

    Volume 104, Issue 1, January 2009, Pages: 35–42, Martina Tvrdonova, Ladislav Dedik, Constantin Mircioiu, Daniela Miklovicova and Maria Durisova

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1742-7843.2008.00304.x

  10. You have free access to this content
    Topical NSAIDs for acute musculoskeletal pain in adults

    Intervention Review

    The Cochrane Library

    Sheena Derry, R Andrew Moore, Helen Gaskell, Mairead McIntyre and Philip J Wiffen

    Published Online : 15 JUN 2015, DOI: 10.1002/14651858.CD007402.pub3

  11. You have full text access to this Open Access content
    Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 1, January/February 2015, Pages: 261–267, S.D. Allstadt, C.O. Rodriguez Jr, B. Boostrom, R.B. Rebhun and K.A. Skorupski

    Version of Record online : 25 JAN 2015, DOI: 10.1111/jvim.12533

  12. You have free access to this content
    Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)

    Intervention Review

    The Cochrane Library

    Féline PB Kroon, Lennart RA van der Burg, Sofia Ramiro, Robert BM Landewé, Rachelle Buchbinder, Louise Falzon and Désirée van der Heijde

    Published Online : 17 JUL 2015, DOI: 10.1002/14651858.CD010952.pub2

  13. 14N Nuclear Quadrupole Resonance Study of Piroxicam: Confirmation of New Polymorphic Form V

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 6, June 2015, Pages: 1909–1918, Zoran Lavrič, Janez Pirnat, Janko Lužnik, Uroš Puc, Zvonko Trontelj and Stane Srčič

    Version of Record online : 16 MAR 2015, DOI: 10.1002/jps.24421

  14. Wound-healing evaluation of entrapped active agents into protein microspheres over cellulosic gauzes

    Biotechnology Journal

    Volume 7, Issue 11, November 2012, Pages: 1376–1385, Raquel Silva, Helena Ferreira, Teresa Matamá, Andreia C. Gomes and Prof. Artur Cavaco-Paulo

    Version of Record online : 1 AUG 2012, DOI: 10.1002/biot.201200142

  15. Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder

    Veterinary and Comparative Oncology

    Volume 3, Issue 2, June 2005, Pages: 73–80, P. A. Boria, N. W. Glickman, B. R. Schmidt, W. R. Widmer, A. J. Mutsaers, L. G. Adams, P. W. Snyder, L. DiBernardi, A. E. De Gortari, P. L. Bonney and D. W. Knapp

    Version of Record online : 10 JUN 2005, DOI: 10.1111/j.1476-5810.2005.00070.x

  16. You have free access to this content
    Piroxicam Reverses Endotoxin-Induced Hypotension in Rats: Contribution of Vasoactive Eicosanoids and Nitric Oxide

    Basic & Clinical Pharmacology & Toxicology

    Volume 109, Issue 3, September 2011, Pages: 186–194, C. Kemal Buharalioglu, Belma Korkmaz, Tuba Cuez, Seyhan Sahan-Firat, Ayse Nihal Sari, Kafait U. Malik and Bahar Tunctan

    Version of Record online : 6 MAY 2011, DOI: 10.1111/j.1742-7843.2011.00708.x

  17. Piroxicam immediate release formulations: A fasting randomized open-label crossover bioequivalence study in healthy volunteers

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 6, November/December 2014, Pages: 466–471, Sally A. Helmy and Heba M. El-Bedaiwy

    Version of Record online : 9 FEB 2014, DOI: 10.1002/cpdd.106

  18. Three-month, zero-order piroxicam release from monodispersed double-walled microspheres of controlled shell thickness

    Journal of Biomedical Materials Research Part A

    Volume 70A, Issue 4, 15 September 2004, Pages: 576–584, Cory Berkland, Amanda Cox, Kyekyoon (Kevin) Kim and Daniel W. Pack

    Version of Record online : 27 JUL 2004, DOI: 10.1002/jbm.a.30114

  19. Host–guest complexation of oxicam NSAIDs with β-cyclodextrin

    Biopolymers

    Volume 75, Issue 4, November 2004, Pages: 355–365, Rona Banerjee, Hirak Chakraborty and Munna Sarkar

    Version of Record online : 15 SEP 2004, DOI: 10.1002/bip.20147

  20. Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 1, January 2016, Pages: 26–35, Arunprasad Sivaraman and Ajay K. Banga

    Version of Record online : 29 DEC 2015, DOI: 10.1111/jphp.12493